1-Boc-3-Hydroxypiperidine CAS 85275-45-2 Ibrutinib Intermediate Purity ≥98.0% (GC)

Inkcazelo emfutshane:

Igama leKhemikhali: 1-Boc-3-Hydroxypiperidine

Izithethantonye: 1-Boc-3-Piperidinol

CAS: 85275-45-2

Imbonakalo: Mhlophe ukuya kwiiCrystals eziMhlophe

Ubunyulu: ≥98.0% (GC)

Umbindi we-Ibrutinib (CAS: 936563-96-1)

Qhagamshelana: UGqr. Alvin Huang

Iselula/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Ubonelelo lwabavelisi ngoBusulungekileyo obuPhezulu kunye noMgangatho oZinzileyo
Igama leKhemikhali: 1-Boc-3-Hydroxypiperidine
CAS: 85275-45-2
Umgangatho ophezulu, iMveliso yoRhwebo

Iipropati zeMichiza:

Igama leMchiza	I-1-Boc-3-Hydroxypiperidine
Izithethantonye	I-1-(tert-Butoxycarbonyl) -3-Hydroxypiperidine;1-Boc-3-Piperidinol
Inombolo yeCAS	85275-45-2
Inombolo yeCAT	RF-PI280
Ubume beStokhwe	Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli	C10H19NO3
Ubunzima beMolekyuli	201.26
Indawo yokunyibilika	65.0 ~ 67.0℃
Imeko yokuthumela ngenqanawa	Ithunyelwe Ngaphantsi Kweqondo Lobushushu Le-Ambient
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Imbonakalo	Okumhlophe Okuqinileyo
I-Infrared Spectrum	Iyahambelana noLwakhiwo
Ubunyulu	≥98.0%
Ilahleko ekomisweni	≤0.50%
Intsalela kwi-Ignition	≤0.20%
Ukungacoceki Okukodwa	≤0.50%
Iintsimbi ezinzima	≤20ppm
Umgangatho woVavanyo	Umgangatho woShishino
Ukusetyenziswa	AbaPhakathi bamayeza

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, Igubu lekhadibhodi, 25kg/Igubu, okanye ngokwemfuno yomthengi.

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.

Izinto eziluncedo:

FAQ:

Isicelo:

I-Shanghai Ruifu Chemical Co., Ltd. ngumenzi ohamba phambili kunye nomthengisi we-1-Boc-3-Hydroxypiperidine (CAS: 85275-45-2) enomgangatho ophezulu, esetyenziswa ngokubanzi kwi-organic synthesis, i-synthesis ye-pharmaceutical intermediates kunye ne-Active Pharmaceutical Ingredient ( API) synthesis.